12 Health Care Stocks Moving In Thursday's Pre-Market Session

 

Gainers

  • AcelRx Pharmaceuticals ACRX stock increased by 61.1% to $0.38 during Thursday's pre-market session. The company's market cap stands at $55.7 million. The company's, Q2 earnings came out today.
  • T2 Biosystems TTOO shares rose 39.05% to $0.22. The market value of their outstanding shares is at $37.7 million.
  • aTyr Pharma LIFE stock increased by 35.12% to $5.04. The company's market cap stands at $141.4 million.
  • Kala Pharmaceuticals KALA stock moved upwards by 35.05% to $0.47. The company's market cap stands at $34.1 million. As per the news, the Q2 earnings report came out today.
  • Cyclacel Pharmaceuticals CYCC stock increased by 23.3% to $1.64. The market value of their outstanding shares is at $16.3 million. The company's, Q2 earnings came out yesterday.
  • Cingulate CING shares moved upwards by 19.39% to $1.97.

Losers

  • Athenex ATNX stock declined by 36.9% to $0.7 during Thursday's pre-market session. The company's market cap stands at $85.1 million.
  • Hyperfine HYPR stock fell 19.48% to $1.5. The market value of their outstanding shares is at $105.4 million. As per the news, the Q2 earnings report came out yesterday.
  • Invitae NVTA stock declined by 19.01% to $6.99. The company's market cap stands at $1.6 billion. The company's, Q2 earnings came out 2 days ago.
  • Landos Biopharma LABP shares fell 11.39% to $1.09. The company's market cap stands at $43.8 million.
  • ChromaDex CDXC shares declined by 10.2% to $1.85. The company's market cap stands at $126.4 million. As per the news, the Q2 earnings report came out yesterday.
  • Sanofi SNY stock decreased by 9.45% to $40.93. The market value of their outstanding shares is at $102.3 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!